Abstract This article reviewed the Consensus Recommendations on Pediatric Acute Respiratory Distress Syndrome (ARDS) from the Pediatric Acute Lung Injury Consensus Conference in 2015 and the literature related to drug management of ARDS. The main points of drug management of pediatric ARDS were summarized.
Day RW, Allen EM, Witte MK. A randomized, controlled study of the 1-hour and 24-hour effects of inhaled nitric oxide therapy in children with acute hypoxemic respiratory failure[J]. Chest, 1997, 112(5):1324-1331.
[2]
Dobyns EL, Anas NG, Fortenberry JD, et al. Interactive effects of high-frequency oscillatory ventilation and inhaled nitric oxide in acute hypoxemic respiratory failure in pediatrics[J]. Crit Care Med, 2002, 30(11):2425-2429.
[3]
Afshari A, Brok J, Møller AM, et al. Inhaled nitric oxide for acute respiratory distress syndrome and acute lung injury in adults and children:a systematic review with meta-analysis and trial sequential analysis[J]. Anesth Analg, 2011, 112(6):1411-1421.
[4]
Pediatric Acute Lung Injury Consensus Conference Group. Pediatric acute respiratory distress syndrome:consensus recommendations from the Pediatric Acute Lung Injury Consensus Conference[J]. Pediatr Crit Care Med, 2015, 16(5):428-439.
[5]
Willson DF, Thomas NJ, Tamburro R, et al. Pediatric calfactant in acute respiratory distress syndrome trial[J]. Pediatr Crit Care Med, 2013, 14(7):657-665.
[6]
Valentine SL, Nadkarni VM, Curley MAQ; Pediatric Acute LungInjury Consensus Conference Group. Non-pulmonary treatments for pediatric acute respiratory distress syndrome:proceedings from the Pediatric Acute Lung Injury Consensus Conference[J]. Pediatr Crit Care Med, 2015, 16(5 Suppl 1):S73-S85.
[7]
Guglani L, Jain S, Lodha R. Methylprednisolone therapy in a child with unresolving ARDS[J]. Indian Pediatr, 2006, 43(7):639-642.
[8]
Willson DF, Thomas NJ, Tamburro R, et al. Pediatric calfactant in acute respiratory distress syndrome trial[J]. Pediatr Crit Care Med, 2013, 14(7):657-665.
[9]
Tamburro RF, Kneyber MCJ; Pediatric Acute Lung Injury Consensus Conference Group. Pulmonary specific ancillary treatment for pediatric acute respiratory distress syndrome:proceedings from the Pediatric Acute Lung Injury Consensus Conference[J]. Pediatr Crit Care Med, 2015, 16(5 Suppl 1):S61-S72.
[10]
Papazian L, Forel JM, Gacouin A, et al. Neuromuscular blockers in early acute respiratory distress syndrome[J]. N Engl J Med, 2010, 363(12):1107-1116.
[11]
Wilsterman MEF, de Jager P, Blokpoel R, et al. Short-term effects of neuromuscular blockade on global and regional lung mechanics, oxygenation and ventilation in pediatric acute hypoxemic respiratory failure[J]. Ann Intensive Care, 2016, 6(1):103.
[12]
Pediatric Acute Lung Injury Consensus Conference Group. Pediatric acute respiratory distress syndrome:consensus recommendations from the Pediatric Acute Lung Injury Consensus Conference[J]. Pediatr Crit Care Med, 2015, 16(5):428-439.
[13]
Abdelsalam M, Cheifetz IM. Goal-directed therapy for severely hypoxic patients with acute respiratory distress syndrome:permissive hypoxemia[J]. Respir Care, 2010, 55(11):1483-1490.
[14]
Randolph AG. Management of acute lung injury and acute respiratory distress syndrome in children[J]. Crit Care Med, 2009, 37(8):2448-2454.
